Found: 3133
Select item for more details and to access through your institution.
Updated Study Results Reinforce Survival Benefit of Docetaxel for Men With Advanced, Hormone-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1143
- Publication type:
- Article
Hormone-Resistant Prostate Cancer: New Therapies Needed.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 194
- By:
- Publication type:
- Article
Albumin Bound Pactlitaxel Improves Response Rate vs Docetaxel in Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 109
- Publication type:
- Article
Sifting Through the Multitude of Novel Therapies for Prostate Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1792
- By:
- Publication type:
- Article
Targeting Metastatic Prostate Cancer: The Search for Innovative Systemic Therapies.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1787
- By:
- Publication type:
- Article
Meta-Analysis Shows Benefits of Docetaxel in Patients With Advanced NSCLC.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1132
- Publication type:
- Article
Study of Tesmilifene Plus Docetaxel in Metastatic Breast Cancer Launched.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 11
- Publication type:
- Article
Advanced Non-Small-Cell Lung Cancer: New Data, Therapy Choices, and Challenging Decisions.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 626
- By:
- Publication type:
- Article
Docetaxel Approved for Advanced Stomach Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 5, p. 525
- Publication type:
- Article
DocetaxellTrastuzumab Improves Disease-Free Survival in Early HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 5, p. 475
- Publication type:
- Article
Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 14, p. 1759
- By:
- Publication type:
- Article
Docetaxel Significantly Improves Survival Compared With Paclitaxel in Advanced Breast Cancer Patients.
- Published in:
- 2005
- Publication type:
- Report
The Cappuzzo/Finocchiaro/Trisolini el al Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 8, p. 1003
- By:
- Publication type:
- Article
Perspectives on Salvage Therapy for Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 8, p. 989
- By:
- Publication type:
- Article
Study Shows Best Survival Rates Ever Reported for Patients With Locally Advanced Lung Cancer.
- Published in:
- 2005
- Publication type:
- Report
Earlier Docetaxel-Based Therapy Improves Survival, Reduces Recurrence in Breast Cancer.
- Published in:
- 2005
- Publication type:
- Report
Docetaxel induced pellagroid dematitis.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Serpentine supravenous hyperpigmentation induced by docetaxel.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC).
- Published in:
- Clinical Medicine & Research, 2021, v. 19, n. 2, p. 64, doi. 10.3121/cmr.2021.1573
- By:
- Publication type:
- Article
Treatment - Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 1, p. 34
- By:
- Publication type:
- Article
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 4, p. 151
- Publication type:
- Article
Treatment -- Neoadjuvant and Adjuvant Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 3, p. 109
- By:
- Publication type:
- Article
Treatment - Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2007, v. 19, n. 2, p. 52
- Publication type:
- Article
TREATMENT -- TREATMENT FOR METASTATIC AND ADVANCED DISEASE.
- Published in:
- Current Medical Literature: Breast Cancer, 2005, v. 17, n. 3, p. 73
- Publication type:
- Article
CITATIONS AND CLINICIANS' NOTES: TREATMENT -- METASTATIC AND ADVANCED DISEASE.
- Published in:
- Current Medical Literature: Breast Cancer, 2005, v. 17, n. 1, p. 27
- Publication type:
- Article
CITATIONS AND CLINICIANS' NOTES: TREATMENT - METASTATIC AND ADVANCED DISEASE.
- Published in:
- Current Medical Literature: Breast Cancer, 2004, v. 16, n. 3, p. 69
- Publication type:
- Article
Reversed‐phase high‐performance liquid chromatography: A fast and efficient analytical method to quantify docetaxel‐loaded pegylated liposomes in release study.
- Published in:
- Journal of Separation Science, 2021, v. 44, n. 21, p. 3986, doi. 10.1002/jssc.202100382
- By:
- Publication type:
- Article
Supercritical fluid chromatography coupled with tandem mass spectrometry: A high-efficiency detection technique to quantify Taxane drugs in whole-blood samples.
- Published in:
- Journal of Separation Science, 2017, v. 40, n. 19, p. 3914, doi. 10.1002/jssc.201700536
- By:
- Publication type:
- Article
Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2023, v. 34, n. 10, p. 1, doi. 10.1007/s10856-023-06749-9
- By:
- Publication type:
- Article
Tritiation of azido‐labeled diiodo cabazitaxel (Jevtana) and docetaxel (Taxotere) derivatives to generate <sup>3</sup>H‐photoaffinity probes.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 12, p. 895, doi. 10.1002/jlcr.3675
- By:
- Publication type:
- Article
Synergistic effects of BAY606583 on docetaxel in esophageal cancer through modulation of ERK1/2.
- Published in:
- Cell Biochemistry & Function, 2022, v. 40, n. 6, p. 569, doi. 10.1002/cbf.3726
- By:
- Publication type:
- Article
A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 20, p. 18081, doi. 10.1007/s00432-023-05497-1
- By:
- Publication type:
- Article
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7247, doi. 10.1007/s00432-023-04639-9
- By:
- Publication type:
- Article
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3371, doi. 10.1007/s00432-022-04220-w
- By:
- Publication type:
- Article
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 1849, doi. 10.1007/s00432-022-04109-8
- By:
- Publication type:
- Article
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 4, p. 1443, doi. 10.1007/s00432-022-04023-z
- By:
- Publication type:
- Article
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3511, doi. 10.1007/s00432-022-04248-y
- By:
- Publication type:
- Article
Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 6, p. 1313, doi. 10.1007/s00432-022-03914-5
- By:
- Publication type:
- Article
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 7, p. 1957, doi. 10.1007/s00432-021-03598-3
- By:
- Publication type:
- Article
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 1, p. 89, doi. 10.1007/s00432-017-2536-x
- By:
- Publication type:
- Article
Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 8, p. 1457, doi. 10.1007/s00432-015-1936-z
- By:
- Publication type:
- Article
Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 7, p. 1189, doi. 10.1007/s00432-014-1880-3
- By:
- Publication type:
- Article
Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 7, p. 1137, doi. 10.1007/s00432-014-1675-6
- By:
- Publication type:
- Article
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 2, p. 319, doi. 10.1007/s00432-013-1563-5
- By:
- Publication type:
- Article
Scaling adult dose and schedule of anticancer agents to children.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 2035, doi. 10.1007/s00432-013-1508-z
- By:
- Publication type:
- Article
A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 703, doi. 10.1007/s00432-013-1373-9
- By:
- Publication type:
- Article
First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 12, p. 2003, doi. 10.1007/s00432-012-1280-5
- By:
- Publication type:
- Article
Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 7, p. 1197, doi. 10.1007/s00432-012-1183-5
- By:
- Publication type:
- Article
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 2, p. 221, doi. 10.1007/s00432-011-1091-0
- By:
- Publication type:
- Article
Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 12, p. 1785, doi. 10.1007/s00432-011-1052-7
- By:
- Publication type:
- Article